MOR103
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for MOR103, covering 2014-05-08 to 2014-10-13. Get the full timeline:
Most recent: Clinical Trial Update: Phase Ib Study to Evaluate MOR103 in Multiple Sclerosis [Phase 1, Phase 2]